Redeye Feed

2025-11-13 18:27:00 Mendus (Q3 review) - Executing on updated clinical strategy

2025-11-13 18:24:00 Alzinova (Q3 review) - Regulatory progress in anticipation of a deal

2025-11-13 18:22:00 IDL Diagnostics (Q3 Review) - Temporary headwinds in APAC

2025-11-12 12:04:00 Isofol Medical (Q3 review) - Advancing in the clinic

2025-11-12 11:11:00 Genovis (Q3 Review) - A soft quarter ahead of a strong Q4

2025-11-12 11:10:00 EG7 (Q3 Review) - Cold Iron uncertainty

2025-11-12 11:09:00 BeammWave (Q3 Review) - Period of digestion

2025-11-12 11:08:00 InfraCom (Q3 Review) - Challenging market, improving margins

2025-11-11 10:22:00 Scibase (Q3 Review) - Rights issue of SEK83m to continue the growth journey

2025-11-11 08:37:00 Redeye Initiates Coverage of VEF

2025-11-10 09:48:00 Ascelia Pharma (Q3 review) - Partnering in focus ahead

2025-11-10 09:47:00 RaySearch Laboratories (Q3 Review) - EBIT beat reinforces take on conservative targets

2025-11-10 09:46:00 Catella (Q3 Review) - Cost discipline and integrated segments

2025-11-10 09:45:00 Active Biotech (Q3 Review) - Rights Issue Funds 2026-2027

2025-11-10 09:38:00 Redeye Initiates Coverage of Freja eID Group

2025-11-07 08:56:00 Medivir (Q3 Review) - New Phase II Study

2025-11-07 08:53:00 W5 Solutions (Q3 Review) - Strong year-end in sight

2025-11-07 08:52:00 Xspray Pharm (Q3 update) - Two PDUFA dates in 2026

2025-11-07 08:51:00 Absolent (Q3 Review) - Some positive signs

2025-11-07 08:50:00 GomSpace (Q3 Review) - Upward Revisions of Forecasts and Valuation

2025-11-07 08:49:00 Arise (Q3 Review) - Eventful months to come

2025-11-07 08:48:00 Optomed Q3 (Review) - Solid growth with a positive devices segment development

2025-11-07 08:47:00 Fable Media Group - Guidance Cut, but a Stronger Year Ahead

2025-11-07 08:46:00 Kontigo Care (Q3 Review) - Back to growth with profitability on the rise

2025-11-07 08:45:00 Transtema (Q3 Review) - Focus on profitability in 2026

2025-11-07 08:44:00 NextCell Pharma (Q4 2024/2025 update) - ProTrans-Young readout in Q3 2026

2025-11-07 08:43:00 G5 Entertainment (Q3 Review) - Improved prospects for a growth turnaround

2025-11-07 08:41:00 Devyser Diagnostics (Q3 Review) - Exaggerated reaction, strong Q4 ahead

2025-11-07 08:40:00 Cheffelo (Q3 Review) - Dish of the quarter, returned untouched

2025-11-07 08:39:00 Oncopeptides (Q3 Update) - Q/Q Growth Only 5%, but 2026 Looks Promising

2025-11-07 08:38:00 Bredband2 (Q3 Review) - All Eyes on Regulatory Approvals

2025-11-07 08:37:00 Neola Medical (Q3 Review) - Revised timeline

2025-11-05 16:27:00 Freemelt (Q3 Review) - Maintaining strong momentum

2025-11-05 11:15:00 Serstech (Q3 Review) - Market turning with share at 52-week low

2025-11-05 11:14:00 Scandinavian ChemoTech (Q3 Review) - Strong momentum in revenue from treatment kits

2025-11-04 13:51:00 IRLAB Therapeutics (Q3 review) - Approaching study initiation

2025-11-04 13:50:00 Xbrane Biopharma (Q3 update) - Headwinds have continued

2025-11-03 11:40:00 Hansa Biopharma (Q3 Update) - Europe Below Expectations, but the US Will Drive Value

2025-11-03 10:39:00 Redeye Initiates Coverage of Boreo

2025-11-03 10:37:00 CTEK (Q3 Update) - Product launches in the spotlight

2025-11-03 10:36:00 Tradedoubler (Q3 Review) - Investing for Growth

2025-11-03 10:35:00 Modelon (Q3 Review) - Efficiency gains and expanding use cases

2025-10-31 11:44:00 SynAct (Q3 Update) - ADVANCE Approaching Full Recruitment

2025-10-30 14:52:00 OncoZenge (Q3 review) - Gearing up for a transformative 2026

2025-10-30 14:50:00 BioInvent (Q3 Update) - Phase II in NSCLC up and Running

2025-10-30 14:49:00 Senzime (Q3 Review) - In the right direction

2025-10-29 09:28:00 Truecaller (Q3 Review) - Soft quarter, strong foundation

2025-10-28 11:47:00 Annexin (Q3’25 Review) - Clinical study in focus

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

Redeye

Språk

Typ

År

Språk

Typ

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden